Anxiolytics (N05B) |
---|
GABAA PAMs | Benzodiazepine | Adinazolam • Alprazolam • Bretazenil • Bromazepam • Camazepam • Chlordiazepoxide • Clobazam • Clonazepam • Clorazepate • Clotiazepam • Cloxazolam • Diazepam • Ethyl Loflazepate • Etizolam • Fludiazepam • Halazepam • Imidazenil • Ketazolam • Lorazepam • Medazepam • Nordazepam • Oxazepam • Pinazepam • Prazepam |
---|
Carbamates | Emylcamate • Mebutamate • Meprobamate (Carisoprodol, Tybamate) • Phenprobamate • Procymate |
---|
Nonbenzodiazepines | Abecarnil • Adipiplon • Alpidem • CGS-8216 • CGS-9896 • CGS-13767 • CGS-20625 • Divaplon • ELB-139 • Fasiplon • GBLD-345 • Gedocarnil • L-838,417 • NS-2664 • NS-2710 • Ocinaplon • Pagoclone • Panadiplon • Pipequaline • RWJ-51204 • SB-205,384 • SL-651,498 • Taniplon • TP-003 • TP-13 • TPA-023 • Y-23684 • ZK-93423 |
---|
Pyrazolopyridines | Cartazolate • Etazolate • ICI-190,622 • Tracazolate |
---|
Others | Chlormezanone • Ethanol (Alcohol) • Etifoxine • Kavalactones (Kava Kava) • Skullcap • Valerenic Acid (Valerian) |
---|
|
---|
α2δ VDCC Blockers | Gabapentin • Pregabalin |
---|
5-HT1A Agonists | Azapirones: Buspirone • Gepirone • Tandospirone; Others: Flesinoxan • Oxaflozane |
---|
H1 Antagonists | Diphenylmethanes: Captodiame • Hydroxyzine; Others: Brompheniramine • Chlorpheniramine • Pheniramine |
---|
CRH1 Antagonists | Antalarmin • CP-154,526 • Pexacerfont • Pivagabine |
---|
NK2 Antagonists | GR-159,897 • Saredutant |
---|
MCH1 antagonists | ATC-0175 • SNAP-94847 |
---|
mGluR2/3 Agonists | Eglumegad |
---|
mGluR5 NAMs | Fenobam |
---|
TSPO agonists | DAA-1097 • DAA-1106 • Emapunil • FGIN-127 • FGIN-143 |
---|
σ1 agonists | Afobazole • Opipramol |
---|
Others | Benzoctamine • Carbetocin • Demoxytocin • Mephenoxalone • Mepiprazole • Oxanamide • Oxytocin • Promoxolane • Tofisopam • Trimetozine • WAY-267,464 |
---|
#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III | | dsrd (o, p, m, p, a, d, s), sysi/epon, spvo | proc, drug(N5A/5B/5C/6A/6B/6D) |
|
|